| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.2 | 0.2 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.2 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.2 | 0.2 |